quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:24:22·44d
SECFiling
Rocket Pharmaceuticals Inc. logo

Rocket Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits

RCKT· Rocket Pharmaceuticals Inc.
Health Care
Original source

Companies

  • RCKT
    Rocket Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Nov 18UpdateAnalyst-
  • Aug 20UpdateBofA Securities$10.00
  • Jul 25UpdateBofA Securities$4.00
  • May 30UpdateEvercore ISI$5.00
  • May 28UpdateAnalyst-
  • May 28UpdateGoldman$2.00

Related

  • SEC17d
    SEC Form DEFA14A filed by Rocket Pharmaceuticals Inc.
  • SEC17d
    SEC Form DEF 14A filed by Rocket Pharmaceuticals Inc.
  • SEC20d
    SEC Form SC TO-C filed by Rocket Pharmaceuticals Inc.
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Rocket Pharmaceuticals Inc.
  • SEC27d
    Rocket Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR27d
    Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
  • SEC30d
    SEC Form PRE 14A filed by Rocket Pharmaceuticals Inc.
  • SEC44d
    SEC Form EFFECT filed by Rocket Pharmaceuticals Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022